Xevant
PrivateLast Round
Series A
Extension
Feb 8, 2024
Total Funding Raised
$17.22M
Company Overview
Xevant is a healthcare technology company that provides a real-time, AI-powered analytics platform for organizations managing pharmacy benefits.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Vertical SaaS, Business Intelligence, Workflow Automation, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xevant Comps
Public and private peers based on sector, stage, and business model.
Xevant Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Feb 8, 2024 | ||||
| Debt | Mar 14, 2023 | ||||
| Series A | Dec 29, 2021 | ||||
| Growth Equity | Jan 6, 2021 |
Key People
Founding team and executive leadership
Xevant Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Decathlon Capital Partners | Series A |
| Tech Council Ventures | Series A Extension, Growth Equity |
| Boston Millennia Partners | Growth Equity |
| Martinson Ventures | Growth Equity |
| HCAP Partners | Series A Extension, Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 29, 2026
Named a 2025 Modern Healthcare Best in Business company.
- Jun 11, 2025
Launched VerX, a new platform for pharmacy benefit optimization.
Xevant Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xevant's valuation, stock price, and market status.
